Contact Us

How Global Negative Pressure Wound Therapy Market Players Should Strategize For 2022-2031

25 May, 2022

The global negative pressure wound therapy market size is expected to grow from $2.13 billion in 2021 to $2.26 billion in 2022 at a compound annual growth rate (CAGR) of 5.88%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global negative pressure wound therapy market size is expected to reach $2.68 billion in 2026 at a CAGR of 5.87%.

What is the Global Negative Pressure Wound Therapy Market?

The negative pressure wound therapy (NPWT) market consists of sales of vacuum-assisted wound closure by entities (organizations, sole traders, and partnerships) that are used to draw out fluid and infection from a wound to help it heal. The negative pressure wound therapy uses a special dressing, tubing, a negative pressure device, and canister to continuously apply subatmospheric pressure to the surface of a wound to assist healing for treating many acute and chronic wounds.

Get a Sample of the global negative pressure wound therapy market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=5687&type=smp

What drives the Global Negative Pressure Wound Therapy Market?

The growing prevalence of diabetes is expected to propel the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) is the most common application area of negative pressure wound therapy. A diabetic person's wounds are difficult to heal because people with uncontrolled diabetes may develop poor circulation which results in less oxygen circulation to the wound and the tissues do not heal as quickly. Thus, negative pressure wound therapy offers better graft take up than the conventional dressing for diabetic patients. According to the International Diabetes Federation (IDF), in 2020, nearly 463 million people had diabetes in the world. The number of diabetic people in Southeast Asia region is expected to increase from 88 million in 2020 to nearly 153 million by 2045. Therefore, the growing prevalence of diabetes drives the negative pressure wound therapy market.

Get the full global negative pressure wound therapy industry report here

https://www.thebusinessresearchcompany.com/report/negative-pressure-wound-therapy-global-market-report

Global Negative Pressure Wound Therapy Market Segments
The global negative pressure wound therapy market is segmented:
By Product: Conventional NPWT Devices, Single-Use NPWT Devices
By Wound Type: Surgical and Traumatic Wounds, Ulcers, Burns
By End-User: Hospitals, Homecare, Others
By Geography: The regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Negative Pressure Wound Therapy Global Market Report 2022provides market size and growth forecasts for the global negative pressure wound therapy market, global negative pressure wound therapy market share, negative pressure wound therapy market segments and geographies, negative pressure wound therapy market competitive landscape including leading competitors’ revenues, profiles and market shares. The negative pressure wound therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Negative Pressure Wound Therapy Industry Playersinclude Devon International Group, ConvaTec Group plc, DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc, Mölnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, TRIAGE MEDITECH PVT. LTD., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd. and KCI Licensing Inc. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.